Larimar Therapeutics (LRMR) Institutional Ownership $3.36 +0.13 (+3.86%) As of 02:20 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Larimar Therapeutics (NASDAQ:LRMR)CurrentInstitutional OwnershipPercentage91.92%Number ofInstitutional Buyers(last 12 months)56TotalInstitutional Inflows(last 12 months)$80.03MNumber ofInstitutional Sellers(last 12 months)23TotalInstitutional Outflows(last 12 months)$26.25M Get LRMR Insider Trade Alerts Want to know when executives and insiders are buying or selling Larimar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LRMR Institutional Buying and Selling by Quarter Larimar Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026Bank of America Corp DE47,359$213K0.0%+17.0%0.046% 5/18/2026ADAR1 Capital Management LLC52,745$237K0.0%-71.6%0.051% 5/16/2026 SummitTX Capital L.P.379,765$1.71M0.1%N/A0.366% 5/14/2026 Renaissance Technologies LLC739,942$3.33M0.0%+148.9%0.712% 5/14/2026 Inceptionr LLC44,006$198K0.0%N/A0.042% 5/14/2026 Sei Investments Co.16,336$74K0.0%+54.5%0.016% 5/7/2026 Dimensional Fund Advisors LP798,462$3.59M0.0%+143.8%0.769% 5/5/2026 Bank of New York Mellon Corp107,331$483K0.0%-7.4%0.103% 4/30/2026 AIGH Capital Management LLC3,000,000$13.50M1.8%+50.0%2.888% 4/28/2026 B.O.S.S. Retirement Advisors LLC12,154$55K0.0%-15.8%0.012% Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/25/2026 Strs Ohio21,700$98K0.0%+174.7%0.021% 2/18/2026 XTX Topco Ltd118,938$453K0.0%+127.1%0.144% 2/18/2026 Quadrature Capital Ltd57,646$220K0.0%+195.4%0.070% 2/18/2026 Millennium Management LLC5,206,364$19.84M0.0%+7.2%6.289% 2/18/2026 Man Group plc39,225$149K0.0%N/A0.047% 2/18/2026 Caption Management LLC415,294$1.58M0.0%-85.4%0.502% 2/18/2026 Bridgeway Capital Management LLC111,216$424K0.0%+42.2%0.134% 2/17/2026ADAR1 Capital Management LLC185,689$707K0.1%-21.2%0.224% 2/17/2026 Schonfeld Strategic Advisors LLC61,759$235K0.0%N/A0.075% 2/17/2026 J. Goldman & Co LP40,500$154K0.0%-88.0%0.049% 2/17/2026 AQR Capital Management LLC502,251$1.91M0.0%-10.7%0.607% 2/17/2026 Jump Financial LLC96,074$366K0.0%N/A0.116% 2/17/2026 Price T Rowe Associates Inc. MD29,008$111K0.0%+26.3%0.035% 2/17/2026 ExodusPoint Capital Management LP344,246$1.31M0.0%+111.4%0.416% 2/17/2026 Graham Capital Management L.P.42,255$161K0.0%N/A0.051% 2/16/2026 Squarepoint Ops LLC30,416$116K0.0%N/A0.037% 2/16/2026 Barclays PLC78,470$299K0.0%+10.7%0.095% 2/13/2026 Alyeska Investment Group L.P.927,821$3.54M0.0%-50.8%1.121% 2/13/2026 State Street Corp911,925$3.47M0.0%+2.2%1.102% 2/13/2026 Ieq Capital LLC49,150$187K0.0%-24.2%0.059% 2/13/2026 Wells Fargo & Company MN56,897$217K0.0%+48.0%0.069% 2/12/2026 Jane Street Group LLC678,942$2.59M0.0%+53.5%0.820% 2/12/2026 MetLife Investment Management LLC13,597$52K0.0%-47.1%0.016% 2/12/2026 Commonwealth Equity Services LLC22,848$87K0.0%N/A0.028% 2/12/2026 Renaissance Technologies LLC297,266$1.13M0.0%-65.4%0.359% 2/12/2026 Dimensional Fund Advisors LP327,494$1.25M0.0%+482.1%0.396% 2/12/2026 EntryPoint Capital LLC53,321$203K0.1%N/A0.064% 2/12/2026 Federated Hermes Inc.358,907$1.37M0.0%+14,885.7%0.434% 2/12/2026 Marex Group plc312,000$1.19M0.0%+121.3%0.377% 2/11/2026 Deutsche Bank AG34,390$131K0.0%-37.5%0.042% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.2/11/2026 Cerity Partners LLC234,737$894K0.0%-1.8%0.284% 2/10/2026 Goldman Sachs Group Inc.1,347,215$5.13M0.0%-14.5%1.627% 2/10/2026 AXQ Capital LP17,655$67K0.0%-53.3%0.021% 2/9/2026 Geode Capital Management LLC1,093,323$4.17M0.0%+6.9%1.321% 2/9/2026 Blue Owl Capital Holdings LP6,823,690$26.00M2.0%+16.6%8.243% 2/2/2026 AIGH Capital Management LLC2,000,000$7.62M1.9%+100.0%2.416% 1/26/2026 CWM LLC32,631$124K0.0%-9.4%0.039% 1/9/2026 SG Americas Securities LLC15,757$60K0.0%N/A0.019% 1/1/2026 JPMorgan Chase & Co.25,261$82K0.0%-54.6%0.031% 12/1/2025 Cantor Fitzgerald L. P.127,500$412K0.0%N/A0.154% 11/19/2025 Coldstream Capital Management Inc.17,533$57K0.0%N/A0.021% 11/17/2025 Woodline Partners LP1,622,850$5.24M0.0%+160.6%1.960% 11/17/2025 Alyeska Investment Group L.P.1,887,169$6.10M0.0%-9.1%2.280% 11/17/2025Bank of America Corp DE28,147$91K0.0%-42.1%0.034% 11/17/2025 Cantor Fitzgerald L. P.127,500$412K0.0%N/A0.154% 11/17/2025 Alliancebernstein L.P.74,530$241K0.0%+19.5%0.090% 11/14/2025 Creative Planning64,279$208K0.0%N/A0.078% 11/14/2025 Virtu Financial LLC102,680$332K0.0%+119.6%0.124% 11/14/2025 Deerfield Management Company L.P.30,606,974$98.86M1.5%+44.2%36.974% 11/14/2025 Two Sigma Investments LP134,729$435K0.0%-85.1%0.163% 11/14/2025 Bridgeway Capital Management LLC78,216$253K0.0%-24.2%0.094% 11/14/2025 Mangrove Partners IM LLC442,236$1.43M0.1%-42.6%0.534% 11/13/2025 UBS Group AG257,999$833K0.0%+138.1%0.312% 11/13/2025 BNP Paribas Financial Markets10,146$33K0.0%+75.8%0.012% 11/13/2025 Blue Owl Capital Holdings LP5,853,040$18.91M5.8%+18.8%7.071% 11/12/2025 Dimensional Fund Advisors LP56,257$182K0.0%+79.4%0.068% 11/12/2025 Intech Investment Management LLC21,220$69K0.0%-18.3%0.026% 11/10/2025 AXQ Capital LP37,771$122K0.0%+90.3%0.046% 11/7/2025 GSA Capital Partners LLP81,406$263K0.0%-18.5%0.098% 11/7/2025Vanguard Group Inc.3,087,840$9.97M0.0%+44.2%3.730% 11/7/2025 JPMorgan Chase & Co.25,261$82K0.0%-54.6%0.031% 11/5/2025 B.O.S.S. Retirement Advisors LLC12,719$41K0.0%N/A0.015% 10/31/2025 AIGH Capital Management LLC1,000,000$3.23M0.9%N/A1.208% 10/29/2025 Wealth Enhancement Advisory Services LLC18,248$59K0.0%+33.9%0.022% 10/23/2025 Next Level Private LLC41,700$135K0.0%+108.5%0.050% 10/17/2025 Ethic Inc.75,397$244K0.0%+22.2%0.091% 10/15/2025 CWM LLC36,013$116K0.0%+10.3%0.044% 8/15/2025 Opaleye Management Inc.4,110,000$11.88M2.4%+114.7%4.965% 8/15/2025 Massar Capital Management LP51,556$149K0.1%N/A0.062% 8/14/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC307,198$888K0.0%+70.6%0.371% 8/14/2025 Velan Capital Investment Management LP33,000$95K0.1%+17.9%0.040% 8/14/2025 Cerity Partners LLC220,201$636K0.0%N/A0.266% 8/12/2025 XTX Topco Ltd167,404$484K0.0%N/A0.202% 8/12/2025 American Century Companies Inc.69,285$200K0.0%+7.8%0.084% 8/12/2025 JPMorgan Chase & Co.55,648$161K0.0%-13.9%0.067% 8/8/2025 Intech Investment Management LLC25,963$75K0.0%-23.5%0.041% 8/8/2025 Geode Capital Management LLC904,425$2.61M0.0%-0.4%1.413% 8/6/2025 Savant Capital LLC13,444$39K0.0%N/A0.021% 7/30/2025 Ethic Inc.61,723$187K0.0%N/A0.096% 7/25/2025 CWM LLC32,652$94K0.0%+205.0%0.051% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.7/11/2025 Assenagon Asset Management S.A.256,861$742K0.0%+17.6%0.401% 7/10/2025 Wealth Enhancement Advisory Services LLC13,629$44K0.0%N/A0.021% 7/8/2025 Next Level Private LLC20,000$58K0.0%N/A0.031% 6/27/2025 Goldman Sachs Group Inc.2,671,271$5.74M0.0%-35.7%4.172% 5/29/2025Rhumbline Advisers65,018$140K0.0%+15.7%0.102% 5/21/2025Acadian Asset Management LLC53,239$113K0.0%N/A0.083% 5/16/2025Goldman Sachs Group Inc.2,671,271$5.74M0.0%-35.7%4.172% 5/16/2025AQR Capital Management LLC112,226$241K0.0%N/A0.175% 5/16/2025Alyeska Investment Group L.P.1,442,473$3.10M0.0%+46.6%2.253% 5/15/2025Cubist Systematic Strategies LLC354,232$762K0.0%+51.5%0.553% LRMR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LRMR shares? During the previous two years, 107 institutional investors and hedge funds held shares of Larimar Therapeutics. The most heavily invested institutionals were Deerfield Management Company L.P. ($98.86M), Blue Owl Capital Holdings LP ($26.00M), Janus Henderson Group PLC ($24.94M), Millennium Management LLC ($19.84M), AIGH Capital Management LLC ($13.50M), Opaleye Management Inc. ($11.88M), and Vanguard Group Inc. ($9.97M).Learn more on Larimar Therapeutics' institutional investors. What percentage of Larimar Therapeutics' stock is owned by institutional investors? 91.92% of Larimar Therapeutics' stock is owned by institutional investors. Learn more on LRMR's institutional investor holdings. Which institutional investors have been buying Larimar Therapeutics' stock? Of the 88 institutional investors that purchased Larimar Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deerfield Management Company L.P. ($9.38M), AIGH Capital Management LLC ($3M), Blue Owl Capital Holdings LP ($2.38M), Opaleye Management Inc. ($2.20M), Janus Henderson Group PLC ($2.07M), Woodline Partners LP ($1.00M), and Vanguard Group Inc. ($945.81K). How much institutional buying is happening at Larimar Therapeutics? Institutional investors have bought a total of 23,430,305 shares in the last 24 months. This purchase volume represents approximately $80.03M in transactions. Which of Larimar Therapeutics' major shareholders have been selling company stock? Of the 23 institutional investors that sold Larimar Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Caption Management LLC ($2.44M), Goldman Sachs Group Inc. ($1.71M), Alyeska Investment Group L.P. ($1.15M), Two Sigma Investments LP ($768.88K), Renaissance Technologies LLC ($561.38K), Mangrove Partners IM LLC ($328.00K), and J. Goldman & Co LP ($298.22K). How much institutional selling is happening at Larimar Therapeutics? Institutional investors have sold a total of 7,730,287 shares in the last 24 months. This volume of shares sold represents approximately $26.25M in transactions. Related Companies Monte Rosa Therapeutics Major Shareholders Amylyx Pharmaceuticals Major Shareholders Phibro Animal Health Major Shareholders Iovance Biotherapeutics Major Shareholders AbCellera Biologics Major Shareholders Immatics Major Shareholders Precigen Major Shareholders Immunocore Major Shareholders Biohaven Major Shareholders Bicara Therapeutics Major Shareholders This page (NASDAQ:LRMR) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Larimar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
